While biglycan is mostly known as a structural element of the ECM, more recent studies have identified critical roles for increased biglycan expression in tumor initiation and progression by playing a role as a signaling molecule in the regulation of inflammation, angiogenesis and autophagy [15,19,20,21]. The gene discussed is BGN; the disease is neoplasm.